Naringin treatment significantly reduced characteristic cytokines of AD including IL4, IL13, TARC/CCL17, MDC/CCL22, IFN-γ, IL1β, and TNF-α (Figure 5). This evidence concerns the gene CCL17 and Alzheimer disease.